公开(公告)号：US20240279305A1

公开(公告)日：2024-08-22

申请号：US18637627

申请日：2024-04-17

Applicant: Alector LLC

Inventor： Spencer Liang ,  Samuel Nalle ,  Jeonghoon Sun ,  Rashmi Bankoti ,  Hua Long

IPC: C07K14/705 ,  A61K38/17 ,  A61K39/00 ,  A61K45/06 ,  A61P35/00 ,  A61P35/04 ,  C07K16/28

CPC classification number: C07K14/70503 ,  A61K38/1774 ,  A61K45/06 ,  A61P35/00 ,  A61P35/04 ,  C07K16/2818 ,  C07K16/2827 ,  A61K2039/545 ,  C07K2317/76 ,  C07K2319/30

Abstract: The present disclosure is generally directed to Siglec-9 ECDs and Siglec-9 ECD fusion molecules, and methods of treatment using Siglec-9 ECDs and Siglec-9 ECD fusion molecules.

公开(公告)号：US20210284710A1

公开(公告)日：2021-09-16

申请号：US17088149

申请日：2020-11-03

Applicant: Alector LLC

Inventor： Spencer Liang ,  Samuel Nalle ,  Jeonghoon Sun ,  Hua Long ,  Rashmi Bankoti

IPC: C07K14/705 ,  A61P35/00 ,  A61P35/04 ,  C07K16/28 ,  A61K45/06 ,  A61K38/17

Abstract: The present disclosure is generally directed to Siglec-9 ECDs and Siglec-9 ECD fusion molecules, and methods of treatment using Siglec-9 ECDs and Siglec-9 ECD fusion molecules.

公开(公告)号：US11987612B2

公开(公告)日：2024-05-21

申请号：US17088149

申请日：2020-11-03

Applicant: Alector LLC

Inventor： Spencer Liang ,  Samuel Nalle ,  Jeonghoon Sun ,  Hua Long ,  Rashmi Bankoti

IPC: C07K14/705 ,  A61K38/17 ,  A61K39/00 ,  A61K45/06 ,  A61P35/00 ,  A61P35/04 ,  C07K16/28

CPC classification number: C07K14/70503 ,  A61K38/1774 ,  A61K45/06 ,  A61P35/00 ,  A61P35/04 ,  C07K16/2818 ,  C07K16/2827 ,  A61K2039/545 ,  C07K2317/76 ,  C07K2319/30

Abstract: The present disclosure is generally directed to Siglec-9 ECDs and Siglec-9 ECD fusion molecules, and methods of treatment using Siglec-9 ECDs and Siglec-9 ECD fusion molecules.

公开(公告)号：US11667699B2

公开(公告)日：2023-06-06

申请号：US16943123

申请日：2020-07-30

Applicant: Alector LLC

Inventor： Jeonghoon Sun ,  Wei-Hsien Ho ,  Muhammad A. Alhawagri ,  Philip Ling Kong ,  Herve Rhinn ,  Hua Long ,  Karpagam Srinivasan ,  Ananya Mitra ,  Daniel P. Bermingham ,  Klaus-Dieter Heger ,  Santiago Viveros Salazar ,  Francesca Cignarella ,  Ilaria Tassi ,  Tina Schwabe ,  Angie Grace Yee ,  Arnon Rosenthal

IPC: C07K16/18 ,  A61K39/00

CPC classification number: C07K16/18 ,  A61K2039/505 ,  C07K2317/24 ,  C07K2317/31 ,  C07K2317/34 ,  C07K2317/732 ,  C07K2317/734 ,  C07K2317/92

Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, humanized antibodies and antibody fragments, that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.